Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$9.80
+0.72%
Mkt Cap $740.12M
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+160.2%
Consensus $25.50 vs current $9.80
NASDAQ·Healthcare·Biotechnology
$9.80
+0.72%
Mkt Cap $740.12M
Buy
8
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
+160.2%
Consensus $25.50 vs current $9.80